Which are the causes of Proteus syndrome?

TL;DR: Proteus syndrome is caused by a sporadic, post-zygotic somatic mutation in the AKT1 gene, which triggers abnormal and disproportionate overgrowth of various tissues. Because this mutation occurs after conception rather than being inherited from parents, Proteus syndrome is not passed down to offspring and is not caused by environmental factors.

What causes Proteus syndrome at the genetic level?

The primary cause of Proteus syndrome is a specific genetic "typo" in the AKT1 gene. In a healthy body, the AKT1 gene acts like a master switch that tells cells when to grow and when to stop. In Proteus syndrome, a somatic mutation—meaning a change that happens in a single cell after fertilization—causes this switch to get stuck in the "on" position. This leads to the mosaic pattern characteristic of the condition, where some body tissues carry the mutation while others do not. Because this mutation occurs randomly in the developing embryo, it is not an inherited condition; it is a "mosaic" disorder, meaning the individual has a mixture of genetically normal and mutated cells.

Is Proteus syndrome hereditary?

No, Proteus syndrome is not hereditary. Because the AKT1 mutation occurs spontaneously during early fetal development, it is not present in the parents’ sperm or egg cells. Consequently, there is no increased risk of a parent having another child with Proteus syndrome, nor can an affected individual pass the condition to their children. It is important to distinguish between the cause (the AKT1 mutation) and risk factors; there are no known environmental, lifestyle, or dietary risk factors that contribute to the development of this condition.

How does the AKT1 mutation lead to overgrowth?

The AKT1 mutation disrupts the body's complex signaling pathways. To understand this, think of the body as a construction site: normally, the AKT1 gene acts as a foreman who tells workers exactly how much material to use. In Proteus syndrome, the foreman is constantly shouting "build more," causing tissues to grow in an uncontrolled, asymmetric, and disproportionate fashion. This results in the hallmark features of the disease, including:

• Cerebriform connective tissue nevi: Raised, grooved skin lesions that often resemble the surface of a brain.


• Asymmetric overgrowth: Disproportionate growth of bones, skin, and fat, often affecting limbs or one side of the body.


• Vascular malformations: Abnormal development of blood vessels, such as capillary or venous malformations.


• Lipose tumors: Overgrowth of fatty tissue in specific regions of the body.

Is the cause of Proteus syndrome fully understood?

While researchers have identified the AKT1 gene mutation as the driver of Proteus syndrome, the field is still actively studying why the severity and location of the overgrowth vary so significantly between patients. Current research is focused on understanding the "timing" of the mutation—exactly when in early development the mutation occurs—and how this timing influences which tissues are affected. Scientists are also investigating targeted therapies that could potentially "turn off" the overactive AKT1 pathway, offering hope for managing the progression of the condition.

Next steps

• Consult a clinical geneticist to confirm the diagnosis through specialized, high-depth sequencing (often requiring biopsy of affected tissue rather than a standard blood test).


• Connect with the DiseaseMaps.org community to share experiences with the 5 other members who have navigated this rare diagnosis.


• Establish care with a multidisciplinary team, including orthopedists, dermatologists, and specialists familiar with overgrowth syndromes.


• Monitor clinical trial databases like ClinicalTrials.gov for emerging therapies targeting the PI3K/AKT pathway.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult a qualified healthcare professional for diagnosis and treatment.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: Proteus Syndrome.


• OMIM (Online Mendelian Inheritance in Man): Proteus Syndrome (Entry #176920).


• Lindhurst, M. J., et al. (2011). "A Mosaic Activating Mutation in AKT1 Associated with the Proteus Syndrome." New England Journal of Medicine.


• Orphanet: Proteus Syndrome (ORPHA:744).